AUTHOR INDEX
| |
|
|
|
|
|
Search results for: "H"
Results 161 - 170 of 610 shown below |
|
| Hatch, John P |
|
| Koji Matsuo, Consuelo Walss-Bass, Fabiano G Nery, Mark A Nicoletti, John P Hatch, Benicio N Frey, Emel S Monkul, Giovana B Zunta-Soares, Charles L Bowden, Michael A Escamilla and Jair C Soares Neuronal Correlates of Brain-derived Neurotrophic Factor Val66Met Polymorphism and Morphometric Abnormalities in Bipolar Disorder doi:10.1038/npp.2009.23 Neuropsychopharmacology 34, 1904-1913 | Abstract | Full text | PDF | |
|
| Hattori, Eiji |
|
| Tetsuo Ohnishi, Tetsuo Ohnishi, Kazuo Yamada, Kazuo Yamada, Hisako Ohba, Hisako Ohba, Yoshimi Iwayama, Yoshimi Iwayama, Tomoko Toyota, Tomoko Toyota, Eiji Hattori, Eiji Hattori, Toshiya Inada, Toshiya Inada, Hiroshi Kunugi, Hiroshi Kunugi, Masahiko Tatsumi, Masahiko Tatsumi, Norio Ozaki, Norio Ozaki, Nakao Iwata, Nakao Iwata, Kaoru Sakamoto, Kaoru Sakamoto, Yoshimi Iijima, Yoshimi Iijima, Yasuhide Iwata, Yasuhide Iwata, Kenji J Tsuchiya, Kenji J Tsuchiya, Genichi Sugihara, Genichi Sugihara, Shinichiro Nanko, Shinichiro Nanko, Noriko Osumi, Noriko Osumi, Sevilla D Detera-Wadleigh, Sevilla D Detera-Wadleigh, Tadafumi Kato, Tadafumi Kato, Takeo Yoshikawa and Takeo Yoshikawa A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription doi:10.1038/sj.npp.1301307 Neuropsychopharmacology 32, 1727-1737 | Abstract | Full text | PDF | |
|
| Tetsuo Ohnishi, Tetsuo Ohnishi, Kazuo Yamada, Kazuo Yamada, Hisako Ohba, Hisako Ohba, Yoshimi Iwayama, Yoshimi Iwayama, Tomoko Toyota, Tomoko Toyota, Eiji Hattori, Eiji Hattori, Toshiya Inada, Toshiya Inada, Hiroshi Kunugi, Hiroshi Kunugi, Masahiko Tatsumi, Masahiko Tatsumi, Norio Ozaki, Norio Ozaki, Nakao Iwata, Nakao Iwata, Kaoru Sakamoto, Kaoru Sakamoto, Yoshimi Iijima, Yoshimi Iijima, Yasuhide Iwata, Yasuhide Iwata, Kenji J Tsuchiya, Kenji J Tsuchiya, Genichi Sugihara, Genichi Sugihara, Shinichiro Nanko, Shinichiro Nanko, Noriko Osumi, Noriko Osumi, Sevilla D Detera-Wadleigh, Sevilla D Detera-Wadleigh, Tadafumi Kato, Tadafumi Kato, Takeo Yoshikawa and Takeo Yoshikawa A Promoter Haplotype of the Inositol Monophosphatase 2 Gene (IMPA2) at 18p11.2 Confers a Possible Risk for Bipolar Disorder by Enhancing Transcription doi:10.1038/sj.npp.1301307 Neuropsychopharmacology 32, 1727-1737 | Abstract | Full text | PDF | |
|
| Hatzidimitriou, George |
|
| William E Fantegrossi, William L Woolverton, Michael Kilbourn, Phillip Sherman, Jie Yuan, George Hatzidimitriou, George A Ricaurte, James H Woods and Gail Winger Behavioral and Neurochemical Consequences of Long-Term Intravenous Self-Administration of MDMA and Its Enantiomers by Rhesus Monkeys doi:10.1038/sj.npp.1300442 Neuropsychopharmacology 29, 1270-1281 | Abstract | Full text | PDF | |
|
| William E Fantegrossi, James H Woods, Gail Winger, Michael Kilbourn, Phillip Sherman, William L Woolverton, Jie Yuan, George Hatzidimitriou and George A Ricaurte Reply: MDMA and the Loss of Reinforcement in Fantegrossi et al (2004) doi:10.1038/sj.npp.1300539 Neuropsychopharmacology 29, 1942-1942 | Abstract | Full text | PDF | |
|
| Annis Mechan, Jie Yuan, George Hatzidimitriou, Rodney J Irvine, Una D McCann and George A Ricaurte Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons doi:10.1038/sj.npp.1300808 Neuropsychopharmacology 31, 339-350 | Abstract | Full text | PDF | |
|
| Tao Xie, Liqiong Tong, Michael W McLane, George Hatzidimitriou, Jie Yuan, Una McCann and George Ricaurte Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines doi:10.1038/sj.npp.1301031 Neuropsychopharmacology 31, 2639-2651 | Abstract | Full text | PDF | |
|
| Tao Xie, Liqiong Tong, Michael W McLane, George Hatzidimitriou, Jie Yuan, Una McCann and George Ricaurte Loss of Serotonin Transporter Protein after MDMA and Other Ring-Substituted Amphetamines doi:10.1038/sj.npp.1301427 Neuropsychopharmacology 33, 712-713 | Abstract | Full text | PDF | |
|
| Michael A Taffe, Sophia A Davis, Jie Yuan, Richard Schroeder, George Hatzidimitriou, Loren H Parsons, George A Ricaurte and Lisa H Gold Cognitive Performance of MDMA-Treated Rhesus Monkeys: Sensitivity to Serotonergic Challenge doi:10.1016/S0893-133X(02)00380-9 Neuropsychopharmacology 27, 993-1005 | Abstract | Full text | PDF | |
|
| Hatzinger, Martin |
|
| Erich Seifritz, Pierre Baumann, Matthias J Müller, Oliver Annen, Marlyse Amey, Ulrich Hemmeter, Martin Hatzinger, François Chardon and Edith Holsboer-Trachsler Neuroendocrine Effects of a 20-mg Citalopram Infusion in Healthy Males doi:10.1016/0893-133X(95)00117-V Neuropsychopharmacology 14, 253-263 | Abstract | PDF | |
|
| Haueisen, Jens |
|
| Timm Rosburg, Varvara Marinou, Jens Haueisen, Stefan Smesny and Heinrich Sauer Effects of Lorazepam on the Neuromagnetic Mismatch Negativity (MMNm) and Auditory Evoked Field Component N100m doi:10.1038/sj.npp.1300477 Neuropsychopharmacology 29, 1723-1733 | Abstract | Full text | PDF | |
|
| Haugbol, Steven |
|
| David Erritzoe, Hans Rasmussen, Klaus T Kristiansen, Vibe G Frokjaer, Steven Haugbol, Lars Pinborg, William Baaré, Claus Svarer, Jacob Madsen, Henrik Lublin, Gitte M Knudsen and Birte Y Glenthoj Cortical and Subcortical 5-HT2A Receptor Binding in Neuroleptic-Naive First-Episode Schizophrenic Patients doi:10.1038/sj.npp.1301656 Neuropsychopharmacology 33, 2435-2441 | Abstract | Full text | PDF | |
|
| Hauger, Richard L |
|
| Emil F Coccaro, Richard J Kavoussi, Thomas B Cooper and Richard L Hauger Hormonal Responses to d- and d,l-Fenfluramine in Healthy Human Subjects doi:10.1016/S0893-133X(96)00133-9 Neuropsychopharmacology 15, 595-607 | Abstract | PDF | |
|
| Ann M Rasmusson, Steven M Southwick, Richard L Hauger and Dennis S Charney Plasma Neuropeptide Y (NPY) Increases in Humans in Response to the 2 Antagonist Yohimbinedoi:10.1016/S0893-133X(97)00199-1 Neuropsychopharmacology 19, 95-98 | Abstract | Full text | PDF | |
|
| Victoria B Risbrough, Mark A Geyer, Richard L Hauger, Sarah Coste, Mary Stenzel-Poore, Wolfgang Wurst and Florian Holsboer CRF1 and CRF2 Receptors are Required for Potentiated Startle to Contextual but not Discrete Cues doi:10.1038/npp.2008.205 Neuropsychopharmacology 34, 1494-1503 | Abstract | Full text | PDF | |
|
| Haupt, Dan |
|
| Dan Haupt and John Newcomer Reply: Plasma Leptin and Antipsychotic-Induced Body Weight Gain doi:10.1038/sj.npp.1300793 Neuropsychopharmacology 30, 1770-1771 | Abstract | Full text | PDF | |
|
| Haupt, Dan W |
|
| Dan W Haupt, Angela Luber, Justin Maeda, Angela K Melson, Julie A Schweiger and John W Newcomer Plasma Leptin and Adiposity During Antipsychotic Treatment of Schizophrenia doi:10.1038/sj.npp.1300563 Neuropsychopharmacology 30, 184-191 | Abstract | Full text | PDF | |
|
| Dan W Haupt, Peter A Fahnestock, Karen A Flavin, Julie A Schweiger, Angela Stevens, Martha J Hessler, Justin Maeda, Michael Yingling and John W Newcomer Adiposity and Insulin Sensitivity Derived from Intravenous Glucose Tolerance Tests in Antipsychotic-Treated Patients doi:10.1038/sj.npp.1301392 Neuropsychopharmacology 32, 2561-2569 | Abstract | Full text | PDF | |
|
| Hauser, Joanna |
|
| Nader Perroud, Katherine J Aitchison, Rudolf Uher, Rebecca Smith, Patricia Huezo-Diaz, Andrej Marusic, Wolfgang Maier, Ole Mors, Anna Placentino, Neven Henigsberg, Marcella Rietschel, Joanna Hauser, Daniel Souery, Pawel Kapelski, Cristian Bonvicini, Astrid Zobel, Lisbeth Jorgensen, Ana Petrovic, Petra Kalember, Thomas G Schulze, Bhanu Gupta, Joanna Gray, Cathryn M Lewis, Anne E Farmer, Peter McGuffin and Ian Craig Genetic Predictors of Increase in Suicidal Ideation During Antidepressant Treatment in the GENDEP Project doi:10.1038/npp.2009.81 Neuropsychopharmacology 34, 2517-2528 | Abstract | Full text | PDF | |
|
| Result page | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | |
|
| top |
|

2 Antagonist Yohimbine
